Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Domiphen Bromide
2. Domiphen Chloride
3. Domiphen Hydroxide
1. Phenododecinium
2. Domiphen Cation
3. Domiphen Ion
4. 13900-14-6
5. Dodecyl-dimethyl-(2-phenoxyethyl)azanium
6. 4azl56cu0f
7. Dodecyldimethyl(2-phenoxyethyl)ammonium
8. 1-dodecanaminium, N,n-dimethyl-n-(2-phenoxyethyl)
9. Ncgc00091010-03
10. Unii-4azl56cu0f
11. Domiphen [vandf]
12. Domiphen [who-dd]
13. Schembl1702653
14. Chembl1187011
15. Dtxsid2048080
16. Yxupzgkorwtxid-uhfffaoysa-
17. Chebi:135978
18. Zinc6845992
19. Stl257462
20. Akos022105914
21. Db11594
22. (beta-phenoxyethyl)dimethyldodecylammonium
23. Ncgc00091010-02
24. Ncgc00091010-04
25. Ncgc00091010-05
26. Dodecyl-dimethyl-(2-phenoxyethyl)ammonium
27. Ab01566921_01
28. Dodecyl-dimethyl-(2-phenoxyethyl)azanium Bromide
29. N,n-dimethyl-n-(2-phenoxyethyl)dodecan-1-aminium
30. (.beta.-phenoxyethyl)dimethyldodecylammonium
31. Q27098012
| Molecular Weight | 334.6 g/mol |
|---|---|
| Molecular Formula | C22H40NO+ |
| XLogP3 | 7.5 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 1 |
| Rotatable Bond Count | 15 |
| Exact Mass | 334.310989899 g/mol |
| Monoisotopic Mass | 334.310989899 g/mol |
| Topological Polar Surface Area | 9.2 Ų |
| Heavy Atom Count | 24 |
| Formal Charge | 1 |
| Complexity | 271 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Anti-infective (topical), it is used for the treatment of Acute Infectious Dental Diseases and other conditions.
The efficacy and tolerability of domiphen bromide (domifen bromide), administered at a dosage of 0.5 mg every 4-6 hr in a double-blind placebo controlled study in 31 patients affected by acute infectious dental diseases, are described. After 2 days of treatment with the drug, there was a significant decrease in pain and inflammation. The drug elicited a good response, improved prognosis and reduced the number of days of illness.
A - Alimentary tract and metabolism
A01 - Stomatological preparations
A01A - Stomatological preparations
A01AB - Antiinfectives and antiseptics for local oral treatment
A01AB06 - Domiphen
Domiphen bromide is a quaternary antiseptic with actions and uses similar to those of cationic surfactants.
ABOUT THIS PAGE
A Zinc6845992 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Zinc6845992, including repackagers and relabelers. The FDA regulates Zinc6845992 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Zinc6845992 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Zinc6845992 supplier is an individual or a company that provides Zinc6845992 active pharmaceutical ingredient (API) or Zinc6845992 finished formulations upon request. The Zinc6845992 suppliers may include Zinc6845992 API manufacturers, exporters, distributors and traders.
Zinc6845992 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Zinc6845992 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Zinc6845992 GMP manufacturer or Zinc6845992 GMP API supplier for your needs.
A Zinc6845992 CoA (Certificate of Analysis) is a formal document that attests to Zinc6845992's compliance with Zinc6845992 specifications and serves as a tool for batch-level quality control.
Zinc6845992 CoA mostly includes findings from lab analyses of a specific batch. For each Zinc6845992 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Zinc6845992 may be tested according to a variety of international standards, such as European Pharmacopoeia (Zinc6845992 EP), Zinc6845992 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Zinc6845992 USP).
LOOKING FOR A SUPPLIER?
